glp-1 agonist and grapefruit GLP1 Receptor Agonists—Effects beyond Obesity Diabetes GLP-1 Unveiled: The Science Behind

11 However, a dose-specific analysis revealed that the beneficial effect of efpeglenatide on HF hospitalisation was primarily seen in the 6 mg group, in which there was a 50% RRR in HF hospitalisation (HR 0.50)

[DOI] [PubMed] [Google Scholar] 37.Marre M, Shaw J, Brndle M, et al

A Reuters analysis of earnings transcripts revealed that mentions of GLP-1 and related terms doubled from 127 in Q2 2023 to 256 mentions in Q3 across 29 U.S

It produces more modest results than semaglutide or tirzepatide, typically around 8 percent body weight loss, but it was the first GLP-1 to receive FDA approval specifically for weight management and remains a viable option for patients who prefer a shorter-acting medication or who experience intolerable side effects on the more potent formulations

24 Effects on the exocrine pancreas GLP-1 is an incretin hormone secreted by the gastrointestinal tract after a meal